Bladder cancer is one of the most common malignant tumors in urinary system, and the treatment faces huge challenges.

Researchers have introduced an innovative surgical technique for treating bladder cancer that could revolutionize the field of urological oncology.

During a Case-Based Roundtable event, Laura Huppert, MD, reviewed antibody-drug conjugates for a patient with metastatic ...

The gut microbiome, or the community of microorganisms residing in the gastrointestinal tract, has emerged as an important ...

Adjuvant ado-trastuzumab emtansine significantly prolonged survival compared with trastuzumab for certain women with ...

In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive disease by 46% and ...

Dual blocking SHP2 and FGFR2 can not only promote the targeted tumor-killing effects and overcome FGFR2 inhibitor resistance caused by feedback activation, but also activate T cell-mediated anti-tumor ...

Breast cancer remains the number one diagnosed cancer in women in the United States, other than skin cancer, according to the ...

Two independent studies reveal that disease progression is delayed by combining two targeted therapies with the traditional ...

What are the symptoms of early stage female colon cancer? At stage 1, colon cancer has not yet grown deeply into nearby tissues or metastasized (spread) to lymph nodes. Early symptoms are likely and ...